| Variables | n = 12 | % |
| Male | 2 | 16.6 |
| Female | 10 | 83.3 |
| Age (years) | 12 | 59 (48.5 - 64) |
| Height (cm) | 12 | 160 (152 - 168) |
| Weight (kg) | 12 | 64.5 (59.5 - 74.5) |
| HBA1C (%) | 5 | 5.7 (5.6 - 5.7) |
| RDW (%) | 12 | 15.7 (13.9 - 16.9) |
| Hemoglobin (g/dl) | 12 | 13.65 (12.9 - 15.5) |
| INR | 12 | 2.4 (2.2 - 3.4) |
| LDL | 12 | 87.5 (73.5 - 102.5) |
| HDL | 12 | 49.6 (40.1 - 56.6) |
| TSH | 9 | 1.9 (1 - 4.8) |
| CRP | 9 | 2.5 (1.6 - 6.1) |
| NT-proBNP | 5 | 673 (613 - 1296) |
| Smoking | 1 | 8.3 |
| Hypertension | 4 | 33.3 |
| Diabetes mellitus | 1 | 8.3 |
| Atrial fibrillation | 5 | 41.6 |
| Atrial flutter | 2 | 16.6 |
| Stroke | 3 | 25 |
| Pacemaker | 1 | 8.3 |
| Coronary artery disease | 1 | 8.3 |
| NYHA functional class > 2 | 4 | 33.3 |
| Indication for valve replacement | n = 12 | 100 |
| Rheumatic valve disease | 9 | 75 |
| Congenital | 1 | 8.3 |
| Degenerative | 1 | 8.3 |
| Infective endocarditis | 1 | 8.3 |
| Left ventricular ejection fraction (%) | 11 | 58 (55 - 62) |
| TAPSE (mm) | 11 | 16 (14 - 20) |
| RV 2D FAC (%) | 7 | 36 (30 - 50) |
| PSAP (mmHg) | 10 | 34 (32 - 38) |